Saffron therapy for the ongoing treatment of age-related macular degeneration
Objective To assess the long-term efficacy and safety of oral saffron, a natural antioxidant, in treating mild/moderate age-related macular degeneration (AMD).Methods and analysis Open-label, extension trial of 93 adults (>50 years) with mild/moderate AMD and vision >20/70 Snellen equi...
Saved in:
Main Authors: | Peter J McCluskey, Thomas Hong, Andrew A Chang, John Grigg, Geoffrey K Broadhead, Timothy E Schlub, Eugenia Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/9/1/e001399.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study
by: Øystein Kalsnes Jørstad, et al.
Published: (2024-12-01) -
Comparison of optical coherence tomography vs. fluorescein angiography-based macular neovascularization classifications in age-related macular degeneration
by: Gábor G. Deák, et al.
Published: (2025-02-01) -
Association of sildenafil use with age-related macular degeneration: a retrospective cohort study
by: Nicola Jaime Adderley, et al.
Published: (2024-04-01) -
Serum lipids mediate the association of per- and polyfluoroalkyl substances exposure and age-related macular degeneration.
by: Xiaodong Chen, et al.
Published: (2025-01-01) -
Modeling pegcetacoplan treatment effect for atrophic age-related macular degeneration with AI-based progression prediction
by: Irmela Mantel, et al.
Published: (2025-02-01)